Novo Nordisk A/S’s chairman said the Danish drugmaker must protect its obesity business from being eroded with falling prices, as the industry pioneer squares off against rapidly strengthening rivals.
www.bloomberg.com
#Novo #Guard #Obesity #Drug #Price #War #Chairman
Novo Must Guard Against Obesity Drug Price War, Chairman Says
